On and effective January 26, 2021, the Board of Directors of Akebia Therapeutics, Inc. appointed Violetta Cotreau as the Company's principal accounting officer. David A. Spellman, who had previously been designated as the Company's principal accounting officer, will continue in his roles as the Company's Senior Vice President, Chief Financial Officer, Treasurer and principal financial officer. Ms. Cotreau joined the Company as its Senior Vice President and Chief Accounting Officer in December 2020. From December 2016 to November 2020, Ms. Cotreau held various positions at AMAG Pharmaceuticals, Inc., most recently as Senior Vice President and Corporate Controller and before that as Vice President, Corporate Controller and Executive Director of Accounting and Corporate Controller, where she led, among other processes, the accounting function for AMAG.